60 Degrees Pharmaceuticals, Inc. (SXTP)

NASDAQ: SXTP · Real-Time Price · USD

1.440

0.00 (0.00%)

Sep 17, 2025, 4:00 PM EDT - Market closed

SXTP Employees

60 Degrees Pharmaceuticals had 3 employees as of December 31, 2024. The number of employees did not change compared to the previous year.

Employees

3

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

$328,165

Profits / Employee

-$2,769,166

Market Cap

5.91M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	3	0	-
Dec 31, 2023	3	1	50.00%
Dec 31, 2022	2	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

SXTP News

14 days ago - 60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
27 days ago - 60 Degrees Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
4 weeks ago - 60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis - GlobeNewsWire
5 weeks ago - 60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results - GlobeNewsWire
2 months ago - 60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering - GlobeNewsWire
2 months ago - 60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering - GlobeNewsWire
2 months ago - 60 Degrees Pharmaceuticals Defines Potential Human Babesiosis Market Size for ARAKODA® (tafenoquine): Annual Max TAM, Sales of $245 Million; Cumulative through Patent Expiration, $1.1 Billion - GlobeNewsWire
3 months ago - 60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format - GlobeNewsWire